context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
For Exelon, reflects the nondeductible transaction costs of approximately $ 12 million arising as part of the separation and indemnification adjustments pursuant to the Tax Matters Agreement of $ 9 million. | text | 9 | monetaryItemType | text: <entity> 9 </entity> <entity type> monetaryItemType </entity type> <context> For Exelon, reflects the nondeductible transaction costs of approximately $ 12 million arising as part of the separation and indemnification adjustments pursuant to the Tax Matters Agreement of $ 9 million. </context> | us-gaap:IncomeTaxReconciliationOtherAdjustments |
For PECO, the lower effective tax rate is primarily related to plant basis differences attributable to tax repair deductions. For BGE, the income tax benefit is primarily due to the Maryland multi-year plan which resulted in the acceleration of certain income tax benefits. For Pepco, the lower effective tax rate is primarily related to the acceleration of certain income tax benefits due to transmission and distribution rate case settlements. For DPL, the higher effective tax rate is primarily related to a state income tax expense, net of federal income tax benefit, due to the recognition of a valuation allowance of approximately $ 31 million against a deferred tax asset associated with Delaware net operating loss carryforwards as a result of a change in Delaware tax law. For ACE, the income tax benefit is primarily due to a distribution rate case settlement which allows ACE to retain certain tax benefits. | text | 31 | monetaryItemType | text: <entity> 31 </entity> <entity type> monetaryItemType </entity type> <context> For PECO, the lower effective tax rate is primarily related to plant basis differences attributable to tax repair deductions. For BGE, the income tax benefit is primarily due to the Maryland multi-year plan which resulted in the acceleration of certain income tax benefits. For Pepco, the lower effective tax rate is primarily related to the acceleration of certain income tax benefits due to transmission and distribution rate case settlements. For DPL, the higher effective tax rate is primarily related to a state income tax expense, net of federal income tax benefit, due to the recognition of a valuation allowance of approximately $ 31 million against a deferred tax asset associated with Delaware net operating loss carryforwards as a result of a change in Delaware tax law. For ACE, the income tax benefit is primarily due to a distribution rate case settlement which allows ACE to retain certain tax benefits. </context> | us-gaap:OperatingLossCarryforwardsValuationAllowance |
At December 31, 2023 and 2022, Exelon recorded a receivable of $ 31 million and $ 50 million, respectively, in noncurrent Other assets in the Consolidated Balance Sheet for Constellation’s share of unrecognized tax benefits for periods prior to the separation. | text | 31 | monetaryItemType | text: <entity> 31 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023 and 2022, Exelon recorded a receivable of $ 31 million and $ 50 million, respectively, in noncurrent Other assets in the Consolidated Balance Sheet for Constellation’s share of unrecognized tax benefits for periods prior to the separation. </context> | us-gaap:IncomeTaxesReceivableNoncurrent |
At December 31, 2023 and 2022, Exelon recorded a receivable of $ 31 million and $ 50 million, respectively, in noncurrent Other assets in the Consolidated Balance Sheet for Constellation’s share of unrecognized tax benefits for periods prior to the separation. | text | 50 | monetaryItemType | text: <entity> 50 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023 and 2022, Exelon recorded a receivable of $ 31 million and $ 50 million, respectively, in noncurrent Other assets in the Consolidated Balance Sheet for Constellation’s share of unrecognized tax benefits for periods prior to the separation. </context> | us-gaap:IncomeTaxesReceivableNoncurrent |
At December 31, 2023, ACE has approximately $ 14 million of unrecognized state tax benefits that could significantly decrease within the 12 months after the reporting date based on the outcome of pending court cases involving other taxpayers. The unrecognized tax benefit, if recognized, may be included in future base rates and that portion would have no impact to the effective tax rate. | text | 14 | monetaryItemType | text: <entity> 14 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, ACE has approximately $ 14 million of unrecognized state tax benefits that could significantly decrease within the 12 months after the reporting date based on the outcome of pending court cases involving other taxpayers. The unrecognized tax benefit, if recognized, may be included in future base rates and that portion would have no impact to the effective tax rate. </context> | us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit |
At December 31, 2023, Exelon classified $ 21 million and $ 41 million of the interest receivable as current and noncurrent, respectively, based on the expected timing for settlement in cash. At December 31, 2023, Exelon recorded a receivable of $ 5 million in noncurrent Other assets in the Consolidated Balance Sheet for Constellation's share of net interest for periods prior to the separation. | text | 21 | monetaryItemType | text: <entity> 21 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, Exelon classified $ 21 million and $ 41 million of the interest receivable as current and noncurrent, respectively, based on the expected timing for settlement in cash. At December 31, 2023, Exelon recorded a receivable of $ 5 million in noncurrent Other assets in the Consolidated Balance Sheet for Constellation's share of net interest for periods prior to the separation. </context> | us-gaap:InterestReceivableCurrent |
At December 31, 2023, Exelon classified $ 21 million and $ 41 million of the interest receivable as current and noncurrent, respectively, based on the expected timing for settlement in cash. At December 31, 2023, Exelon recorded a receivable of $ 5 million in noncurrent Other assets in the Consolidated Balance Sheet for Constellation's share of net interest for periods prior to the separation. | text | 41 | monetaryItemType | text: <entity> 41 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, Exelon classified $ 21 million and $ 41 million of the interest receivable as current and noncurrent, respectively, based on the expected timing for settlement in cash. At December 31, 2023, Exelon recorded a receivable of $ 5 million in noncurrent Other assets in the Consolidated Balance Sheet for Constellation's share of net interest for periods prior to the separation. </context> | us-gaap:InterestReceivableNoncurrent |
At December 31, 2023, Exelon classified $ 21 million and $ 41 million of the interest receivable as current and noncurrent, respectively, based on the expected timing for settlement in cash. At December 31, 2023, Exelon recorded a receivable of $ 5 million in noncurrent Other assets in the Consolidated Balance Sheet for Constellation's share of net interest for periods prior to the separation. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, Exelon classified $ 21 million and $ 41 million of the interest receivable as current and noncurrent, respectively, based on the expected timing for settlement in cash. At December 31, 2023, Exelon recorded a receivable of $ 5 million in noncurrent Other assets in the Consolidated Balance Sheet for Constellation's share of net interest for periods prior to the separation. </context> | us-gaap:OtherAssetsNoncurrent |
At December 31, 2022, the interest receivable balance is not expected to be settled in cash within the next twelve months and is therefore classified as a noncurrent receivable. At December 31, 2022, Exelon recorded a receivable of $ 1 million in noncurrent Other assets in the Consolidated Balance Sheet for Constellation's share of net interest for periods prior to the separation. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2022, the interest receivable balance is not expected to be settled in cash within the next twelve months and is therefore classified as a noncurrent receivable. At December 31, 2022, Exelon recorded a receivable of $ 1 million in noncurrent Other assets in the Consolidated Balance Sheet for Constellation's share of net interest for periods prior to the separation. </context> | us-gaap:OtherAssetsNoncurrent |
In the first quarter of 2022, in connection with the separation, Exelon recorded an income tax expense related to continuing operations of $ 148 million primarily due to the long-term marginal state income tax rate change of $ 54 million discussed further below, the recognition of valuation allowances of approximately $ 40 million against the net deferred tax assets positions for certain standalone state filing jurisdictions, the write-off of federal and state tax credits subject to recapture of $ 17 million, and nondeductible transaction costs for federal and state taxes of $ 24 million. | text | 54 | monetaryItemType | text: <entity> 54 </entity> <entity type> monetaryItemType </entity type> <context> In the first quarter of 2022, in connection with the separation, Exelon recorded an income tax expense related to continuing operations of $ 148 million primarily due to the long-term marginal state income tax rate change of $ 54 million discussed further below, the recognition of valuation allowances of approximately $ 40 million against the net deferred tax assets positions for certain standalone state filing jurisdictions, the write-off of federal and state tax credits subject to recapture of $ 17 million, and nondeductible transaction costs for federal and state taxes of $ 24 million. </context> | us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes |
In the first quarter of 2022, in connection with the separation, Exelon recorded an income tax expense related to continuing operations of $ 148 million primarily due to the long-term marginal state income tax rate change of $ 54 million discussed further below, the recognition of valuation allowances of approximately $ 40 million against the net deferred tax assets positions for certain standalone state filing jurisdictions, the write-off of federal and state tax credits subject to recapture of $ 17 million, and nondeductible transaction costs for federal and state taxes of $ 24 million. | text | 40 | monetaryItemType | text: <entity> 40 </entity> <entity type> monetaryItemType </entity type> <context> In the first quarter of 2022, in connection with the separation, Exelon recorded an income tax expense related to continuing operations of $ 148 million primarily due to the long-term marginal state income tax rate change of $ 54 million discussed further below, the recognition of valuation allowances of approximately $ 40 million against the net deferred tax assets positions for certain standalone state filing jurisdictions, the write-off of federal and state tax credits subject to recapture of $ 17 million, and nondeductible transaction costs for federal and state taxes of $ 24 million. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
In the first quarter of 2022, in connection with the separation, Exelon recorded an income tax expense related to continuing operations of $ 148 million primarily due to the long-term marginal state income tax rate change of $ 54 million discussed further below, the recognition of valuation allowances of approximately $ 40 million against the net deferred tax assets positions for certain standalone state filing jurisdictions, the write-off of federal and state tax credits subject to recapture of $ 17 million, and nondeductible transaction costs for federal and state taxes of $ 24 million. | text | 17 | monetaryItemType | text: <entity> 17 </entity> <entity type> monetaryItemType </entity type> <context> In the first quarter of 2022, in connection with the separation, Exelon recorded an income tax expense related to continuing operations of $ 148 million primarily due to the long-term marginal state income tax rate change of $ 54 million discussed further below, the recognition of valuation allowances of approximately $ 40 million against the net deferred tax assets positions for certain standalone state filing jurisdictions, the write-off of federal and state tax credits subject to recapture of $ 17 million, and nondeductible transaction costs for federal and state taxes of $ 24 million. </context> | us-gaap:IncomeTaxCreditsAndAdjustments |
As a former subsidiary of Exelon, Constellation has joint and several liability with Exelon to the IRS and certain state jurisdictions relating to the taxable periods prior to the separation. The TMA specifies that Constellation is liable for their share of taxes required to be paid by Exelon with respect to taxable periods prior to the separation to the extent Constellation would have been responsible for such taxes under the existing Exelon tax sharing agreement. In 2023, Exelon remitted $ 9 million of payments to Constellation. At December 31, 2023, Exelon recorded a payable of $ 11 million in Other current liabilities that is due to Constellation. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> As a former subsidiary of Exelon, Constellation has joint and several liability with Exelon to the IRS and certain state jurisdictions relating to the taxable periods prior to the separation. The TMA specifies that Constellation is liable for their share of taxes required to be paid by Exelon with respect to taxable periods prior to the separation to the extent Constellation would have been responsible for such taxes under the existing Exelon tax sharing agreement. In 2023, Exelon remitted $ 9 million of payments to Constellation. At December 31, 2023, Exelon recorded a payable of $ 11 million in Other current liabilities that is due to Constellation. </context> | us-gaap:IncomeTaxesReceivable |
. At the date of separation certain tax attributes, primarily pre-closing tax credit carryforwards, that were generated by Constellation were required by law to be allocated to Exelon. The TMA also provides that Exelon will reimburse Constellation when those allocated tax attribute carryforwards are utilized. In 2023, Exelon remitted $ 21 million of payments to Constellation for the utilization of pre-closing tax credit carryforwards. At December 31, 2023, Exelon recorded a payable of $ 182 million and $ 331 million in Other current liabilities and Other deferred credits and other liabilities, respectively, in the Consolidated Balance Sheet for tax attribute carryforwards that are expected to be utilized and reimbursed to Constellation. | text | 182 | monetaryItemType | text: <entity> 182 </entity> <entity type> monetaryItemType </entity type> <context> . At the date of separation certain tax attributes, primarily pre-closing tax credit carryforwards, that were generated by Constellation were required by law to be allocated to Exelon. The TMA also provides that Exelon will reimburse Constellation when those allocated tax attribute carryforwards are utilized. In 2023, Exelon remitted $ 21 million of payments to Constellation for the utilization of pre-closing tax credit carryforwards. At December 31, 2023, Exelon recorded a payable of $ 182 million and $ 331 million in Other current liabilities and Other deferred credits and other liabilities, respectively, in the Consolidated Balance Sheet for tax attribute carryforwards that are expected to be utilized and reimbursed to Constellation. </context> | us-gaap:TaxesPayableCurrentAndNoncurrent |
. At the date of separation certain tax attributes, primarily pre-closing tax credit carryforwards, that were generated by Constellation were required by law to be allocated to Exelon. The TMA also provides that Exelon will reimburse Constellation when those allocated tax attribute carryforwards are utilized. In 2023, Exelon remitted $ 21 million of payments to Constellation for the utilization of pre-closing tax credit carryforwards. At December 31, 2023, Exelon recorded a payable of $ 182 million and $ 331 million in Other current liabilities and Other deferred credits and other liabilities, respectively, in the Consolidated Balance Sheet for tax attribute carryforwards that are expected to be utilized and reimbursed to Constellation. | text | 331 | monetaryItemType | text: <entity> 331 </entity> <entity type> monetaryItemType </entity type> <context> . At the date of separation certain tax attributes, primarily pre-closing tax credit carryforwards, that were generated by Constellation were required by law to be allocated to Exelon. The TMA also provides that Exelon will reimburse Constellation when those allocated tax attribute carryforwards are utilized. In 2023, Exelon remitted $ 21 million of payments to Constellation for the utilization of pre-closing tax credit carryforwards. At December 31, 2023, Exelon recorded a payable of $ 182 million and $ 331 million in Other current liabilities and Other deferred credits and other liabilities, respectively, in the Consolidated Balance Sheet for tax attribute carryforwards that are expected to be utilized and reimbursed to Constellation. </context> | us-gaap:LongTermNotesPayable |
On August 16, 2022, the IRA was signed into law and implemented a new corporate alternative minimum tax (CAMT) that imposes a 15.0 % tax on modified GAAP net income. Corporations are entitled to a tax credit (minimum tax credit) to the extent the CAMT liability exceeds the regular tax liability. This amount can be carried forward indefinitely and used in future years when regular tax exceeds the CAMT. | text | 15.0 | percentItemType | text: <entity> 15.0 </entity> <entity type> percentItemType </entity type> <context> On August 16, 2022, the IRA was signed into law and implemented a new corporate alternative minimum tax (CAMT) that imposes a 15.0 % tax on modified GAAP net income. Corporations are entitled to a tax credit (minimum tax credit) to the extent the CAMT liability exceeds the regular tax liability. This amount can be carried forward indefinitely and used in future years when regular tax exceeds the CAMT. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate |
Quarterly, Exelon reviews and updates its marginal state income tax rates for material changes in state tax laws and state apportionment. The Registrants remeasure their existing deferred income tax balances to reflect the changes in marginal rates, which results in either an increase or a decrease to their net deferred income tax liability balances. Utility Registrants record corresponding regulatory liabilities or assets to the extent such amounts are probable of settlement or recovery through customer rates and an adjustment to income tax expense for all other amounts. In the third quarter of 2023, Exelon updated its marginal state income tax rates for changes in state apportionment. The changes in marginal rates in the third quarter resulted in a decrease of $ 54 million to the deferred tax liability at Exelon, and a corresponding adjustment to income tax expense, net of federal taxes. There were no impacts to ComEd, BGE, PHI, Pepco, DPL, and ACE for the years ended December 31, 2023, 2022, and 2021. | text | 54 | monetaryItemType | text: <entity> 54 </entity> <entity type> monetaryItemType </entity type> <context> Quarterly, Exelon reviews and updates its marginal state income tax rates for material changes in state tax laws and state apportionment. The Registrants remeasure their existing deferred income tax balances to reflect the changes in marginal rates, which results in either an increase or a decrease to their net deferred income tax liability balances. Utility Registrants record corresponding regulatory liabilities or assets to the extent such amounts are probable of settlement or recovery through customer rates and an adjustment to income tax expense for all other amounts. In the third quarter of 2023, Exelon updated its marginal state income tax rates for changes in state apportionment. The changes in marginal rates in the third quarter resulted in a decrease of $ 54 million to the deferred tax liability at Exelon, and a corresponding adjustment to income tax expense, net of federal taxes. There were no impacts to ComEd, BGE, PHI, Pepco, DPL, and ACE for the years ended December 31, 2023, 2022, and 2021. </context> | us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes |
As of February 1, 2022, in connection with the separation, Exelon's pension and OPEB plans were remeasured. The remeasurement and separation resulted in a decrease to the Pension obligation, net of plan assets, of $ 921 million and a decrease to the OPEB obligation of $ 893 million. Additionally, AOCI decreased by $ 1,994 million (after-tax) and Regulatory assets and liabilities increased by $ 14 million and $ 5 million, respectively. Key assumptions were held consistent with the year end December 31, 2021 assumptions with the exception of the discount rate. | text | 921 | monetaryItemType | text: <entity> 921 </entity> <entity type> monetaryItemType </entity type> <context> As of February 1, 2022, in connection with the separation, Exelon's pension and OPEB plans were remeasured. The remeasurement and separation resulted in a decrease to the Pension obligation, net of plan assets, of $ 921 million and a decrease to the OPEB obligation of $ 893 million. Additionally, AOCI decreased by $ 1,994 million (after-tax) and Regulatory assets and liabilities increased by $ 14 million and $ 5 million, respectively. Key assumptions were held consistent with the year end December 31, 2021 assumptions with the exception of the discount rate. </context> | us-gaap:IncreaseDecreaseInPensionPlanObligations |
As of February 1, 2022, in connection with the separation, Exelon's pension and OPEB plans were remeasured. The remeasurement and separation resulted in a decrease to the Pension obligation, net of plan assets, of $ 921 million and a decrease to the OPEB obligation of $ 893 million. Additionally, AOCI decreased by $ 1,994 million (after-tax) and Regulatory assets and liabilities increased by $ 14 million and $ 5 million, respectively. Key assumptions were held consistent with the year end December 31, 2021 assumptions with the exception of the discount rate. | text | 893 | monetaryItemType | text: <entity> 893 </entity> <entity type> monetaryItemType </entity type> <context> As of February 1, 2022, in connection with the separation, Exelon's pension and OPEB plans were remeasured. The remeasurement and separation resulted in a decrease to the Pension obligation, net of plan assets, of $ 921 million and a decrease to the OPEB obligation of $ 893 million. Additionally, AOCI decreased by $ 1,994 million (after-tax) and Regulatory assets and liabilities increased by $ 14 million and $ 5 million, respectively. Key assumptions were held consistent with the year end December 31, 2021 assumptions with the exception of the discount rate. </context> | us-gaap:IncreaseDecreaseInPostretirementObligations |
As of February 1, 2022, in connection with the separation, Exelon's pension and OPEB plans were remeasured. The remeasurement and separation resulted in a decrease to the Pension obligation, net of plan assets, of $ 921 million and a decrease to the OPEB obligation of $ 893 million. Additionally, AOCI decreased by $ 1,994 million (after-tax) and Regulatory assets and liabilities increased by $ 14 million and $ 5 million, respectively. Key assumptions were held consistent with the year end December 31, 2021 assumptions with the exception of the discount rate. | text | 1994 | monetaryItemType | text: <entity> 1994 </entity> <entity type> monetaryItemType </entity type> <context> As of February 1, 2022, in connection with the separation, Exelon's pension and OPEB plans were remeasured. The remeasurement and separation resulted in a decrease to the Pension obligation, net of plan assets, of $ 921 million and a decrease to the OPEB obligation of $ 893 million. Additionally, AOCI decreased by $ 1,994 million (after-tax) and Regulatory assets and liabilities increased by $ 14 million and $ 5 million, respectively. Key assumptions were held consistent with the year end December 31, 2021 assumptions with the exception of the discount rate. </context> | us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax |
During the first quarter of 2023, Exelon received an updated valuation of its pension and OPEB to reflect actual census data as of January 1, 2023. This valuation resulted in an increase to the pension obligation of $ 27 million and an increase to the OPEB obligations of $ 2 million. Additionally, AOCI increased by $ 10 million (after-tax) and Regulatory assets and liabilities increased by $ 18 million and $ 1 million, respectively. | text | 27 | monetaryItemType | text: <entity> 27 </entity> <entity type> monetaryItemType </entity type> <context> During the first quarter of 2023, Exelon received an updated valuation of its pension and OPEB to reflect actual census data as of January 1, 2023. This valuation resulted in an increase to the pension obligation of $ 27 million and an increase to the OPEB obligations of $ 2 million. Additionally, AOCI increased by $ 10 million (after-tax) and Regulatory assets and liabilities increased by $ 18 million and $ 1 million, respectively. </context> | us-gaap:IncreaseDecreaseInPensionPlanObligations |
During the first quarter of 2023, Exelon received an updated valuation of its pension and OPEB to reflect actual census data as of January 1, 2023. This valuation resulted in an increase to the pension obligation of $ 27 million and an increase to the OPEB obligations of $ 2 million. Additionally, AOCI increased by $ 10 million (after-tax) and Regulatory assets and liabilities increased by $ 18 million and $ 1 million, respectively. | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> During the first quarter of 2023, Exelon received an updated valuation of its pension and OPEB to reflect actual census data as of January 1, 2023. This valuation resulted in an increase to the pension obligation of $ 27 million and an increase to the OPEB obligations of $ 2 million. Additionally, AOCI increased by $ 10 million (after-tax) and Regulatory assets and liabilities increased by $ 18 million and $ 1 million, respectively. </context> | us-gaap:IncreaseDecreaseInPostretirementObligations |
During the first quarter of 2023, Exelon received an updated valuation of its pension and OPEB to reflect actual census data as of January 1, 2023. This valuation resulted in an increase to the pension obligation of $ 27 million and an increase to the OPEB obligations of $ 2 million. Additionally, AOCI increased by $ 10 million (after-tax) and Regulatory assets and liabilities increased by $ 18 million and $ 1 million, respectively. | text | 10 | monetaryItemType | text: <entity> 10 </entity> <entity type> monetaryItemType </entity type> <context> During the first quarter of 2023, Exelon received an updated valuation of its pension and OPEB to reflect actual census data as of January 1, 2023. This valuation resulted in an increase to the pension obligation of $ 27 million and an increase to the OPEB obligations of $ 2 million. Additionally, AOCI increased by $ 10 million (after-tax) and Regulatory assets and liabilities increased by $ 18 million and $ 1 million, respectively. </context> | us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax |
The majority of the 2023 pension benefit cost for the Exelon-sponsored plans is calculated using an expected long-term rate of return on plan assets of 7.00 % and a discount rate of 5.53 %. The majority of the 2023 OPEB cost is calculated using an expected long-term rate of return on plan assets of 6.50 % for funded plans and a discount rate of 5.51 %. | text | 7.00 | percentItemType | text: <entity> 7.00 </entity> <entity type> percentItemType </entity type> <context> The majority of the 2023 pension benefit cost for the Exelon-sponsored plans is calculated using an expected long-term rate of return on plan assets of 7.00 % and a discount rate of 5.53 %. The majority of the 2023 OPEB cost is calculated using an expected long-term rate of return on plan assets of 6.50 % for funded plans and a discount rate of 5.51 %. </context> | us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets |
The majority of the 2023 pension benefit cost for the Exelon-sponsored plans is calculated using an expected long-term rate of return on plan assets of 7.00 % and a discount rate of 5.53 %. The majority of the 2023 OPEB cost is calculated using an expected long-term rate of return on plan assets of 6.50 % for funded plans and a discount rate of 5.51 %. | text | 5.53 | percentItemType | text: <entity> 5.53 </entity> <entity type> percentItemType </entity type> <context> The majority of the 2023 pension benefit cost for the Exelon-sponsored plans is calculated using an expected long-term rate of return on plan assets of 7.00 % and a discount rate of 5.53 %. The majority of the 2023 OPEB cost is calculated using an expected long-term rate of return on plan assets of 6.50 % for funded plans and a discount rate of 5.51 %. </context> | us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate |
The majority of the 2023 pension benefit cost for the Exelon-sponsored plans is calculated using an expected long-term rate of return on plan assets of 7.00 % and a discount rate of 5.53 %. The majority of the 2023 OPEB cost is calculated using an expected long-term rate of return on plan assets of 6.50 % for funded plans and a discount rate of 5.51 %. | text | 6.50 | percentItemType | text: <entity> 6.50 </entity> <entity type> percentItemType </entity type> <context> The majority of the 2023 pension benefit cost for the Exelon-sponsored plans is calculated using an expected long-term rate of return on plan assets of 7.00 % and a discount rate of 5.53 %. The majority of the 2023 OPEB cost is calculated using an expected long-term rate of return on plan assets of 6.50 % for funded plans and a discount rate of 5.51 %. </context> | us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets |
The majority of the 2023 pension benefit cost for the Exelon-sponsored plans is calculated using an expected long-term rate of return on plan assets of 7.00 % and a discount rate of 5.53 %. The majority of the 2023 OPEB cost is calculated using an expected long-term rate of return on plan assets of 6.50 % for funded plans and a discount rate of 5.51 %. | text | 5.51 | percentItemType | text: <entity> 5.51 </entity> <entity type> percentItemType </entity type> <context> The majority of the 2023 pension benefit cost for the Exelon-sponsored plans is calculated using an expected long-term rate of return on plan assets of 7.00 % and a discount rate of 5.53 %. The majority of the 2023 OPEB cost is calculated using an expected long-term rate of return on plan assets of 6.50 % for funded plans and a discount rate of 5.51 %. </context> | us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate |
Exelon allocates contributions related to its ECRP and PPBU pension plans and East and West OPEB plans to its subsidiaries based on accounting cost. For the EPP pension plan, PHI Qualified, and PHI PRW plans, pension and OPEB contributions are allocated to the subsidiaries based on employee participation (both active and retired). For Exelon, in connection with the separation, additional qualified pension contributions of $ 207 million and $ 33 million were completed on February 1, 2022 and March 2, 2022, respectively. The following table provides contributions to the pension and OPEB plans: | text | 207 | monetaryItemType | text: <entity> 207 </entity> <entity type> monetaryItemType </entity type> <context> Exelon allocates contributions related to its ECRP and PPBU pension plans and East and West OPEB plans to its subsidiaries based on accounting cost. For the EPP pension plan, PHI Qualified, and PHI PRW plans, pension and OPEB contributions are allocated to the subsidiaries based on employee participation (both active and retired). For Exelon, in connection with the separation, additional qualified pension contributions of $ 207 million and $ 33 million were completed on February 1, 2022 and March 2, 2022, respectively. The following table provides contributions to the pension and OPEB plans: </context> | us-gaap:PensionAndOtherPostretirementBenefitContributions |
Exelon allocates contributions related to its ECRP and PPBU pension plans and East and West OPEB plans to its subsidiaries based on accounting cost. For the EPP pension plan, PHI Qualified, and PHI PRW plans, pension and OPEB contributions are allocated to the subsidiaries based on employee participation (both active and retired). For Exelon, in connection with the separation, additional qualified pension contributions of $ 207 million and $ 33 million were completed on February 1, 2022 and March 2, 2022, respectively. The following table provides contributions to the pension and OPEB plans: | text | 33 | monetaryItemType | text: <entity> 33 </entity> <entity type> monetaryItemType </entity type> <context> Exelon allocates contributions related to its ECRP and PPBU pension plans and East and West OPEB plans to its subsidiaries based on accounting cost. For the EPP pension plan, PHI Qualified, and PHI PRW plans, pension and OPEB contributions are allocated to the subsidiaries based on employee participation (both active and retired). For Exelon, in connection with the separation, additional qualified pension contributions of $ 207 million and $ 33 million were completed on February 1, 2022 and March 2, 2022, respectively. The following table provides contributions to the pension and OPEB plans: </context> | us-gaap:PensionAndOtherPostretirementBenefitContributions |
Management considers various factors when making pension funding decisions, including actuarially determined minimum contribution requirements under ERISA, contributions required to avoid benefit restrictions and at-risk status as defined by the Pension Protection Act of 2006 (the "Act"), management of the pension obligation, and regulatory implications. The Act requires the attainment of certain funding levels to avoid benefit restrictions (such as an inability to pay lump sums or to accrue benefits prospectively), and at-risk status (which triggers higher minimum contribution requirements and participant notification). The projected contributions below reflect a funding strategy to make annual contributions with the objective of achieving 100% funded status on an ABO basis over time. This funding strategy helps minimize volatility of future period required pension contributions. Based on this funding strategy and current market conditions, which are subject to change, Exelon’s estimated annual qualified pension contributions will be approximately $ 93 million in 2024. Unlike the qualified pension plans, Exelon’s non-qualified pension plans are not funded, given they are not subject to statutory minimum contribution requirements. | text | 93 | monetaryItemType | text: <entity> 93 </entity> <entity type> monetaryItemType </entity type> <context> Management considers various factors when making pension funding decisions, including actuarially determined minimum contribution requirements under ERISA, contributions required to avoid benefit restrictions and at-risk status as defined by the Pension Protection Act of 2006 (the "Act"), management of the pension obligation, and regulatory implications. The Act requires the attainment of certain funding levels to avoid benefit restrictions (such as an inability to pay lump sums or to accrue benefits prospectively), and at-risk status (which triggers higher minimum contribution requirements and participant notification). The projected contributions below reflect a funding strategy to make annual contributions with the objective of achieving 100% funded status on an ABO basis over time. This funding strategy helps minimize volatility of future period required pension contributions. Based on this funding strategy and current market conditions, which are subject to change, Exelon’s estimated annual qualified pension contributions will be approximately $ 93 million in 2024. Unlike the qualified pension plans, Exelon’s non-qualified pension plans are not funded, given they are not subject to statutory minimum contribution requirements. </context> | us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount |
Actual asset returns have an impact on the costs reported for the Exelon-sponsored pension and OPEB plans. The actual asset returns across Exelon’s pension and OPEB plans for the year ended December 31, 2023 were 7.73 % and 9.20 %, respectively, compared to an expected long-term return assumption of 7.00 % and 6.50 %, respectively. Exelon used an EROA of 7.00 % and 6.50 % to estimate its 2024 pension and OPEB costs, respectively. | text | 7.00 | percentItemType | text: <entity> 7.00 </entity> <entity type> percentItemType </entity type> <context> Actual asset returns have an impact on the costs reported for the Exelon-sponsored pension and OPEB plans. The actual asset returns across Exelon’s pension and OPEB plans for the year ended December 31, 2023 were 7.73 % and 9.20 %, respectively, compared to an expected long-term return assumption of 7.00 % and 6.50 %, respectively. Exelon used an EROA of 7.00 % and 6.50 % to estimate its 2024 pension and OPEB costs, respectively. </context> | us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets |
Actual asset returns have an impact on the costs reported for the Exelon-sponsored pension and OPEB plans. The actual asset returns across Exelon’s pension and OPEB plans for the year ended December 31, 2023 were 7.73 % and 9.20 %, respectively, compared to an expected long-term return assumption of 7.00 % and 6.50 %, respectively. Exelon used an EROA of 7.00 % and 6.50 % to estimate its 2024 pension and OPEB costs, respectively. | text | 6.50 | percentItemType | text: <entity> 6.50 </entity> <entity type> percentItemType </entity type> <context> Actual asset returns have an impact on the costs reported for the Exelon-sponsored pension and OPEB plans. The actual asset returns across Exelon’s pension and OPEB plans for the year ended December 31, 2023 were 7.73 % and 9.20 %, respectively, compared to an expected long-term return assumption of 7.00 % and 6.50 %, respectively. Exelon used an EROA of 7.00 % and 6.50 % to estimate its 2024 pension and OPEB costs, respectively. </context> | us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets |
Exelon evaluated its pension and OPEB plans’ asset portfolios for the existence of significant concentrations of credit risk as of December 31, 2023. Types of concentrations that were evaluated include, but are not limited to, investment concentrations in a single entity, type of industry, foreign country, and individual fund. As of December 31, 2023, there were no significant concentrations (defined as greater than 10% of plan assets) of risk in Exelon’s pension and OPEB plan assets. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> Exelon evaluated its pension and OPEB plans’ asset portfolios for the existence of significant concentrations of credit risk as of December 31, 2023. Types of concentrations that were evaluated include, but are not limited to, investment concentrations in a single entity, type of industry, foreign country, and individual fund. As of December 31, 2023, there were no significant concentrations (defined as greater than 10% of plan assets) of risk in Exelon’s pension and OPEB plan assets. </context> | us-gaap:FairValueConcentrationOfRiskInvestments |
Includes derivative instruments of $ 51 million and $ 11 million for the years ended December 31, 2023 and 2022, respectively, which have total notional amounts of $ 3,351 million and $ 3,434 million as of December 31, 2023 and 2022, respectively. The notional principal amounts for these instruments provide one measure of the transaction volume outstanding as of the fiscal years ended and do not represent the amount of Exelon's exposure to credit or market loss. | text | 51 | monetaryItemType | text: <entity> 51 </entity> <entity type> monetaryItemType </entity type> <context> Includes derivative instruments of $ 51 million and $ 11 million for the years ended December 31, 2023 and 2022, respectively, which have total notional amounts of $ 3,351 million and $ 3,434 million as of December 31, 2023 and 2022, respectively. The notional principal amounts for these instruments provide one measure of the transaction volume outstanding as of the fiscal years ended and do not represent the amount of Exelon's exposure to credit or market loss. </context> | us-gaap:DerivativeFairValueOfDerivativeNet |
Includes derivative instruments of $ 51 million and $ 11 million for the years ended December 31, 2023 and 2022, respectively, which have total notional amounts of $ 3,351 million and $ 3,434 million as of December 31, 2023 and 2022, respectively. The notional principal amounts for these instruments provide one measure of the transaction volume outstanding as of the fiscal years ended and do not represent the amount of Exelon's exposure to credit or market loss. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> Includes derivative instruments of $ 51 million and $ 11 million for the years ended December 31, 2023 and 2022, respectively, which have total notional amounts of $ 3,351 million and $ 3,434 million as of December 31, 2023 and 2022, respectively. The notional principal amounts for these instruments provide one measure of the transaction volume outstanding as of the fiscal years ended and do not represent the amount of Exelon's exposure to credit or market loss. </context> | us-gaap:DerivativeFairValueOfDerivativeNet |
Includes derivative instruments of $ 51 million and $ 11 million for the years ended December 31, 2023 and 2022, respectively, which have total notional amounts of $ 3,351 million and $ 3,434 million as of December 31, 2023 and 2022, respectively. The notional principal amounts for these instruments provide one measure of the transaction volume outstanding as of the fiscal years ended and do not represent the amount of Exelon's exposure to credit or market loss. | text | 3351 | monetaryItemType | text: <entity> 3351 </entity> <entity type> monetaryItemType </entity type> <context> Includes derivative instruments of $ 51 million and $ 11 million for the years ended December 31, 2023 and 2022, respectively, which have total notional amounts of $ 3,351 million and $ 3,434 million as of December 31, 2023 and 2022, respectively. The notional principal amounts for these instruments provide one measure of the transaction volume outstanding as of the fiscal years ended and do not represent the amount of Exelon's exposure to credit or market loss. </context> | us-gaap:DerivativeNotionalAmount |
Includes derivative instruments of $ 51 million and $ 11 million for the years ended December 31, 2023 and 2022, respectively, which have total notional amounts of $ 3,351 million and $ 3,434 million as of December 31, 2023 and 2022, respectively. The notional principal amounts for these instruments provide one measure of the transaction volume outstanding as of the fiscal years ended and do not represent the amount of Exelon's exposure to credit or market loss. | text | 3434 | monetaryItemType | text: <entity> 3434 </entity> <entity type> monetaryItemType </entity type> <context> Includes derivative instruments of $ 51 million and $ 11 million for the years ended December 31, 2023 and 2022, respectively, which have total notional amounts of $ 3,351 million and $ 3,434 million as of December 31, 2023 and 2022, respectively. The notional principal amounts for these instruments provide one measure of the transaction volume outstanding as of the fiscal years ended and do not represent the amount of Exelon's exposure to credit or market loss. </context> | us-gaap:DerivativeNotionalAmount |
Excludes net liabilities of $ 388 million and $ 318 million as of December 31, 2023 and 2022, respectively, which include certain derivative assets that have notional amounts of $ 59 million and $ 69 million as of December 31, 2023 and 2022, respectively. These items are required to reconcile to the fair value of net plan assets and consist primarily of receivables or payables related to pending securities sales and purchases, interest and dividends receivable, and repurchase agreement obligations. The repurchase agreements generally have maturities ranging from 3 - 6 months. | text | 59 | monetaryItemType | text: <entity> 59 </entity> <entity type> monetaryItemType </entity type> <context> Excludes net liabilities of $ 388 million and $ 318 million as of December 31, 2023 and 2022, respectively, which include certain derivative assets that have notional amounts of $ 59 million and $ 69 million as of December 31, 2023 and 2022, respectively. These items are required to reconcile to the fair value of net plan assets and consist primarily of receivables or payables related to pending securities sales and purchases, interest and dividends receivable, and repurchase agreement obligations. The repurchase agreements generally have maturities ranging from 3 - 6 months. </context> | us-gaap:DerivativeNotionalAmount |
Excludes net liabilities of $ 388 million and $ 318 million as of December 31, 2023 and 2022, respectively, which include certain derivative assets that have notional amounts of $ 59 million and $ 69 million as of December 31, 2023 and 2022, respectively. These items are required to reconcile to the fair value of net plan assets and consist primarily of receivables or payables related to pending securities sales and purchases, interest and dividends receivable, and repurchase agreement obligations. The repurchase agreements generally have maturities ranging from 3 - 6 months. | text | 69 | monetaryItemType | text: <entity> 69 </entity> <entity type> monetaryItemType </entity type> <context> Excludes net liabilities of $ 388 million and $ 318 million as of December 31, 2023 and 2022, respectively, which include certain derivative assets that have notional amounts of $ 59 million and $ 69 million as of December 31, 2023 and 2022, respectively. These items are required to reconcile to the fair value of net plan assets and consist primarily of receivables or payables related to pending securities sales and purchases, interest and dividends receivable, and repurchase agreement obligations. The repurchase agreements generally have maturities ranging from 3 - 6 months. </context> | us-gaap:DerivativeNotionalAmount |
For derivative instruments that qualify and are designated as cash flow hedges, the changes in fair value each period are initially recorded in AOCI and reclassified into earnings when the underlying transaction affects earnings. In January 2023, Exelon Corporate entered into $ 115 million notional of 5-year maturity floating-to-fixed swaps and $ 115 million notional of 10-year maturity floating-to-fixed swaps, for a total of $ 230 million designated as cash flow hedges. In February 2023, Exelon terminated the previously issued floating-to-fixed swaps with a total notional of $ 1.5 billion upon issuance of $ 2.5 billion of debt. See Note 16 – Debt and Credit Agreements for additional information on the debt issuance. Prior to the termination, the AOCI derivative gain was $ 7 million (net of tax). The settlements resulted in a cash receipt of $ 10 million, which is being amortized into Interest expense in Exelon's Consolidated Statement of Operations and Comprehensive Income over the 5-year and 10-year terms of the swaps. | text | 115 | monetaryItemType | text: <entity> 115 </entity> <entity type> monetaryItemType </entity type> <context> For derivative instruments that qualify and are designated as cash flow hedges, the changes in fair value each period are initially recorded in AOCI and reclassified into earnings when the underlying transaction affects earnings. In January 2023, Exelon Corporate entered into $ 115 million notional of 5-year maturity floating-to-fixed swaps and $ 115 million notional of 10-year maturity floating-to-fixed swaps, for a total of $ 230 million designated as cash flow hedges. In February 2023, Exelon terminated the previously issued floating-to-fixed swaps with a total notional of $ 1.5 billion upon issuance of $ 2.5 billion of debt. See Note 16 – Debt and Credit Agreements for additional information on the debt issuance. Prior to the termination, the AOCI derivative gain was $ 7 million (net of tax). The settlements resulted in a cash receipt of $ 10 million, which is being amortized into Interest expense in Exelon's Consolidated Statement of Operations and Comprehensive Income over the 5-year and 10-year terms of the swaps. </context> | us-gaap:DerivativeNotionalAmount |
For derivative instruments that qualify and are designated as cash flow hedges, the changes in fair value each period are initially recorded in AOCI and reclassified into earnings when the underlying transaction affects earnings. In January 2023, Exelon Corporate entered into $ 115 million notional of 5-year maturity floating-to-fixed swaps and $ 115 million notional of 10-year maturity floating-to-fixed swaps, for a total of $ 230 million designated as cash flow hedges. In February 2023, Exelon terminated the previously issued floating-to-fixed swaps with a total notional of $ 1.5 billion upon issuance of $ 2.5 billion of debt. See Note 16 – Debt and Credit Agreements for additional information on the debt issuance. Prior to the termination, the AOCI derivative gain was $ 7 million (net of tax). The settlements resulted in a cash receipt of $ 10 million, which is being amortized into Interest expense in Exelon's Consolidated Statement of Operations and Comprehensive Income over the 5-year and 10-year terms of the swaps. | text | 230 | monetaryItemType | text: <entity> 230 </entity> <entity type> monetaryItemType </entity type> <context> For derivative instruments that qualify and are designated as cash flow hedges, the changes in fair value each period are initially recorded in AOCI and reclassified into earnings when the underlying transaction affects earnings. In January 2023, Exelon Corporate entered into $ 115 million notional of 5-year maturity floating-to-fixed swaps and $ 115 million notional of 10-year maturity floating-to-fixed swaps, for a total of $ 230 million designated as cash flow hedges. In February 2023, Exelon terminated the previously issued floating-to-fixed swaps with a total notional of $ 1.5 billion upon issuance of $ 2.5 billion of debt. See Note 16 – Debt and Credit Agreements for additional information on the debt issuance. Prior to the termination, the AOCI derivative gain was $ 7 million (net of tax). The settlements resulted in a cash receipt of $ 10 million, which is being amortized into Interest expense in Exelon's Consolidated Statement of Operations and Comprehensive Income over the 5-year and 10-year terms of the swaps. </context> | us-gaap:DerivativeNotionalAmount |
For derivative instruments that qualify and are designated as cash flow hedges, the changes in fair value each period are initially recorded in AOCI and reclassified into earnings when the underlying transaction affects earnings. In January 2023, Exelon Corporate entered into $ 115 million notional of 5-year maturity floating-to-fixed swaps and $ 115 million notional of 10-year maturity floating-to-fixed swaps, for a total of $ 230 million designated as cash flow hedges. In February 2023, Exelon terminated the previously issued floating-to-fixed swaps with a total notional of $ 1.5 billion upon issuance of $ 2.5 billion of debt. See Note 16 – Debt and Credit Agreements for additional information on the debt issuance. Prior to the termination, the AOCI derivative gain was $ 7 million (net of tax). The settlements resulted in a cash receipt of $ 10 million, which is being amortized into Interest expense in Exelon's Consolidated Statement of Operations and Comprehensive Income over the 5-year and 10-year terms of the swaps. | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> For derivative instruments that qualify and are designated as cash flow hedges, the changes in fair value each period are initially recorded in AOCI and reclassified into earnings when the underlying transaction affects earnings. In January 2023, Exelon Corporate entered into $ 115 million notional of 5-year maturity floating-to-fixed swaps and $ 115 million notional of 10-year maturity floating-to-fixed swaps, for a total of $ 230 million designated as cash flow hedges. In February 2023, Exelon terminated the previously issued floating-to-fixed swaps with a total notional of $ 1.5 billion upon issuance of $ 2.5 billion of debt. See Note 16 – Debt and Credit Agreements for additional information on the debt issuance. Prior to the termination, the AOCI derivative gain was $ 7 million (net of tax). The settlements resulted in a cash receipt of $ 10 million, which is being amortized into Interest expense in Exelon's Consolidated Statement of Operations and Comprehensive Income over the 5-year and 10-year terms of the swaps. </context> | us-gaap:DerivativeNotionalAmount |
For derivative instruments that qualify and are designated as cash flow hedges, the changes in fair value each period are initially recorded in AOCI and reclassified into earnings when the underlying transaction affects earnings. In January 2023, Exelon Corporate entered into $ 115 million notional of 5-year maturity floating-to-fixed swaps and $ 115 million notional of 10-year maturity floating-to-fixed swaps, for a total of $ 230 million designated as cash flow hedges. In February 2023, Exelon terminated the previously issued floating-to-fixed swaps with a total notional of $ 1.5 billion upon issuance of $ 2.5 billion of debt. See Note 16 – Debt and Credit Agreements for additional information on the debt issuance. Prior to the termination, the AOCI derivative gain was $ 7 million (net of tax). The settlements resulted in a cash receipt of $ 10 million, which is being amortized into Interest expense in Exelon's Consolidated Statement of Operations and Comprehensive Income over the 5-year and 10-year terms of the swaps. | text | 2.5 | monetaryItemType | text: <entity> 2.5 </entity> <entity type> monetaryItemType </entity type> <context> For derivative instruments that qualify and are designated as cash flow hedges, the changes in fair value each period are initially recorded in AOCI and reclassified into earnings when the underlying transaction affects earnings. In January 2023, Exelon Corporate entered into $ 115 million notional of 5-year maturity floating-to-fixed swaps and $ 115 million notional of 10-year maturity floating-to-fixed swaps, for a total of $ 230 million designated as cash flow hedges. In February 2023, Exelon terminated the previously issued floating-to-fixed swaps with a total notional of $ 1.5 billion upon issuance of $ 2.5 billion of debt. See Note 16 – Debt and Credit Agreements for additional information on the debt issuance. Prior to the termination, the AOCI derivative gain was $ 7 million (net of tax). The settlements resulted in a cash receipt of $ 10 million, which is being amortized into Interest expense in Exelon's Consolidated Statement of Operations and Comprehensive Income over the 5-year and 10-year terms of the swaps. </context> | us-gaap:DebtInstrumentFaceAmount |
For derivative instruments that qualify and are designated as cash flow hedges, the changes in fair value each period are initially recorded in AOCI and reclassified into earnings when the underlying transaction affects earnings. In January 2023, Exelon Corporate entered into $ 115 million notional of 5-year maturity floating-to-fixed swaps and $ 115 million notional of 10-year maturity floating-to-fixed swaps, for a total of $ 230 million designated as cash flow hedges. In February 2023, Exelon terminated the previously issued floating-to-fixed swaps with a total notional of $ 1.5 billion upon issuance of $ 2.5 billion of debt. See Note 16 – Debt and Credit Agreements for additional information on the debt issuance. Prior to the termination, the AOCI derivative gain was $ 7 million (net of tax). The settlements resulted in a cash receipt of $ 10 million, which is being amortized into Interest expense in Exelon's Consolidated Statement of Operations and Comprehensive Income over the 5-year and 10-year terms of the swaps. | text | 7 | monetaryItemType | text: <entity> 7 </entity> <entity type> monetaryItemType </entity type> <context> For derivative instruments that qualify and are designated as cash flow hedges, the changes in fair value each period are initially recorded in AOCI and reclassified into earnings when the underlying transaction affects earnings. In January 2023, Exelon Corporate entered into $ 115 million notional of 5-year maturity floating-to-fixed swaps and $ 115 million notional of 10-year maturity floating-to-fixed swaps, for a total of $ 230 million designated as cash flow hedges. In February 2023, Exelon terminated the previously issued floating-to-fixed swaps with a total notional of $ 1.5 billion upon issuance of $ 2.5 billion of debt. See Note 16 – Debt and Credit Agreements for additional information on the debt issuance. Prior to the termination, the AOCI derivative gain was $ 7 million (net of tax). The settlements resulted in a cash receipt of $ 10 million, which is being amortized into Interest expense in Exelon's Consolidated Statement of Operations and Comprehensive Income over the 5-year and 10-year terms of the swaps. </context> | us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax |
For derivative instruments that qualify and are designated as cash flow hedges, the changes in fair value each period are initially recorded in AOCI and reclassified into earnings when the underlying transaction affects earnings. In January 2023, Exelon Corporate entered into $ 115 million notional of 5-year maturity floating-to-fixed swaps and $ 115 million notional of 10-year maturity floating-to-fixed swaps, for a total of $ 230 million designated as cash flow hedges. In February 2023, Exelon terminated the previously issued floating-to-fixed swaps with a total notional of $ 1.5 billion upon issuance of $ 2.5 billion of debt. See Note 16 – Debt and Credit Agreements for additional information on the debt issuance. Prior to the termination, the AOCI derivative gain was $ 7 million (net of tax). The settlements resulted in a cash receipt of $ 10 million, which is being amortized into Interest expense in Exelon's Consolidated Statement of Operations and Comprehensive Income over the 5-year and 10-year terms of the swaps. | text | 10 | monetaryItemType | text: <entity> 10 </entity> <entity type> monetaryItemType </entity type> <context> For derivative instruments that qualify and are designated as cash flow hedges, the changes in fair value each period are initially recorded in AOCI and reclassified into earnings when the underlying transaction affects earnings. In January 2023, Exelon Corporate entered into $ 115 million notional of 5-year maturity floating-to-fixed swaps and $ 115 million notional of 10-year maturity floating-to-fixed swaps, for a total of $ 230 million designated as cash flow hedges. In February 2023, Exelon terminated the previously issued floating-to-fixed swaps with a total notional of $ 1.5 billion upon issuance of $ 2.5 billion of debt. See Note 16 – Debt and Credit Agreements for additional information on the debt issuance. Prior to the termination, the AOCI derivative gain was $ 7 million (net of tax). The settlements resulted in a cash receipt of $ 10 million, which is being amortized into Interest expense in Exelon's Consolidated Statement of Operations and Comprehensive Income over the 5-year and 10-year terms of the swaps. </context> | us-gaap:DerivativeCashReceivedOnHedge |
The AOCI derivative loss (net of tax) was $ 10 million as of December 31, 2023 and gain was $ 2 million as of December 31, 2022. See Note 21 – Changes in Accumulated Other Comprehensive Income (Loss) for additional information. | text | 10 | monetaryItemType | text: <entity> 10 </entity> <entity type> monetaryItemType </entity type> <context> The AOCI derivative loss (net of tax) was $ 10 million as of December 31, 2023 and gain was $ 2 million as of December 31, 2022. See Note 21 – Changes in Accumulated Other Comprehensive Income (Loss) for additional information. </context> | us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax |
Exelon Corporate enters into floating-to-fixed interest rate cap swaps to manage a portion of interest rate exposure in connection with existing borrowings. In 2022, Exelon Corporate entered into $ 1 billion notional of 18-month maturity floating-to-fixed interest rate cap swaps and $ 850 million notional of 6-month maturity floating-to-fixed interest rate cap swaps, for a total of $ 1,850 million notional of floating-to-fixed interest rate cap swaps as of December 31, 2022. The 6-month maturity floating-to-fixed interest rate cap swaps of $ 850 million notional matured in March 2023. Exelon receives payments on the interest rate cap when the floating rate exceeds the fixed rate. Settlements received are immaterial as of December 31, 2023. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> Exelon Corporate enters into floating-to-fixed interest rate cap swaps to manage a portion of interest rate exposure in connection with existing borrowings. In 2022, Exelon Corporate entered into $ 1 billion notional of 18-month maturity floating-to-fixed interest rate cap swaps and $ 850 million notional of 6-month maturity floating-to-fixed interest rate cap swaps, for a total of $ 1,850 million notional of floating-to-fixed interest rate cap swaps as of December 31, 2022. The 6-month maturity floating-to-fixed interest rate cap swaps of $ 850 million notional matured in March 2023. Exelon receives payments on the interest rate cap when the floating rate exceeds the fixed rate. Settlements received are immaterial as of December 31, 2023. </context> | us-gaap:DerivativeNotionalAmount |
Exelon Corporate enters into floating-to-fixed interest rate cap swaps to manage a portion of interest rate exposure in connection with existing borrowings. In 2022, Exelon Corporate entered into $ 1 billion notional of 18-month maturity floating-to-fixed interest rate cap swaps and $ 850 million notional of 6-month maturity floating-to-fixed interest rate cap swaps, for a total of $ 1,850 million notional of floating-to-fixed interest rate cap swaps as of December 31, 2022. The 6-month maturity floating-to-fixed interest rate cap swaps of $ 850 million notional matured in March 2023. Exelon receives payments on the interest rate cap when the floating rate exceeds the fixed rate. Settlements received are immaterial as of December 31, 2023. | text | 850 | monetaryItemType | text: <entity> 850 </entity> <entity type> monetaryItemType </entity type> <context> Exelon Corporate enters into floating-to-fixed interest rate cap swaps to manage a portion of interest rate exposure in connection with existing borrowings. In 2022, Exelon Corporate entered into $ 1 billion notional of 18-month maturity floating-to-fixed interest rate cap swaps and $ 850 million notional of 6-month maturity floating-to-fixed interest rate cap swaps, for a total of $ 1,850 million notional of floating-to-fixed interest rate cap swaps as of December 31, 2022. The 6-month maturity floating-to-fixed interest rate cap swaps of $ 850 million notional matured in March 2023. Exelon receives payments on the interest rate cap when the floating rate exceeds the fixed rate. Settlements received are immaterial as of December 31, 2023. </context> | us-gaap:DerivativeNotionalAmount |
Exelon Corporate enters into floating-to-fixed interest rate cap swaps to manage a portion of interest rate exposure in connection with existing borrowings. In 2022, Exelon Corporate entered into $ 1 billion notional of 18-month maturity floating-to-fixed interest rate cap swaps and $ 850 million notional of 6-month maturity floating-to-fixed interest rate cap swaps, for a total of $ 1,850 million notional of floating-to-fixed interest rate cap swaps as of December 31, 2022. The 6-month maturity floating-to-fixed interest rate cap swaps of $ 850 million notional matured in March 2023. Exelon receives payments on the interest rate cap when the floating rate exceeds the fixed rate. Settlements received are immaterial as of December 31, 2023. | text | 1850 | monetaryItemType | text: <entity> 1850 </entity> <entity type> monetaryItemType </entity type> <context> Exelon Corporate enters into floating-to-fixed interest rate cap swaps to manage a portion of interest rate exposure in connection with existing borrowings. In 2022, Exelon Corporate entered into $ 1 billion notional of 18-month maturity floating-to-fixed interest rate cap swaps and $ 850 million notional of 6-month maturity floating-to-fixed interest rate cap swaps, for a total of $ 1,850 million notional of floating-to-fixed interest rate cap swaps as of December 31, 2022. The 6-month maturity floating-to-fixed interest rate cap swaps of $ 850 million notional matured in March 2023. Exelon receives payments on the interest rate cap when the floating rate exceeds the fixed rate. Settlements received are immaterial as of December 31, 2023. </context> | us-gaap:DerivativeNotionalAmount |
Additionally, to manage potential fluctuations in Electric operating revenues related to ComEd's distribution formula rate, Exelon Corporate entered into a total of $ 4,875 million notional of 30-year constant maturity treasury interest rate (Corporate 30-year treasury) swaps from 2022 through 2023. The Corporate 30-year treasury swaps matured on December 31, 2023 and Exelon recorded a Mark-to-market liability of $ 22 million for the final settlement amount, which was paid in January 2024. | text | 4875 | monetaryItemType | text: <entity> 4875 </entity> <entity type> monetaryItemType </entity type> <context> Additionally, to manage potential fluctuations in Electric operating revenues related to ComEd's distribution formula rate, Exelon Corporate entered into a total of $ 4,875 million notional of 30-year constant maturity treasury interest rate (Corporate 30-year treasury) swaps from 2022 through 2023. The Corporate 30-year treasury swaps matured on December 31, 2023 and Exelon recorded a Mark-to-market liability of $ 22 million for the final settlement amount, which was paid in January 2024. </context> | us-gaap:DerivativeNotionalAmount |
Additionally, to manage potential fluctuations in Electric operating revenues related to ComEd's distribution formula rate, Exelon Corporate entered into a total of $ 4,875 million notional of 30-year constant maturity treasury interest rate (Corporate 30-year treasury) swaps from 2022 through 2023. The Corporate 30-year treasury swaps matured on December 31, 2023 and Exelon recorded a Mark-to-market liability of $ 22 million for the final settlement amount, which was paid in January 2024. | text | 22 | monetaryItemType | text: <entity> 22 </entity> <entity type> monetaryItemType </entity type> <context> Additionally, to manage potential fluctuations in Electric operating revenues related to ComEd's distribution formula rate, Exelon Corporate entered into a total of $ 4,875 million notional of 30-year constant maturity treasury interest rate (Corporate 30-year treasury) swaps from 2022 through 2023. The Corporate 30-year treasury swaps matured on December 31, 2023 and Exelon recorded a Mark-to-market liability of $ 22 million for the final settlement amount, which was paid in January 2024. </context> | us-gaap:DerivativeLiabilities |
Includes revolving credit agreements at Exelon Corporate with a maximum program size of $ 900 million as of December 31, 2023 and December 31, 2022. Exelon Corporate had $ 527 million in outstanding commercial paper as of December 31, 2023 and $ 449 million outstanding commercial paper as of December 31, 2022. | text | 527 | monetaryItemType | text: <entity> 527 </entity> <entity type> monetaryItemType </entity type> <context> Includes revolving credit agreements at Exelon Corporate with a maximum program size of $ 900 million as of December 31, 2023 and December 31, 2022. Exelon Corporate had $ 527 million in outstanding commercial paper as of December 31, 2023 and $ 449 million outstanding commercial paper as of December 31, 2022. </context> | us-gaap:CommercialPaper |
Includes revolving credit agreements at Exelon Corporate with a maximum program size of $ 900 million as of December 31, 2023 and December 31, 2022. Exelon Corporate had $ 527 million in outstanding commercial paper as of December 31, 2023 and $ 449 million outstanding commercial paper as of December 31, 2022. | text | 449 | monetaryItemType | text: <entity> 449 </entity> <entity type> monetaryItemType </entity type> <context> Includes revolving credit agreements at Exelon Corporate with a maximum program size of $ 900 million as of December 31, 2023 and December 31, 2022. Exelon Corporate had $ 527 million in outstanding commercial paper as of December 31, 2023 and $ 449 million outstanding commercial paper as of December 31, 2022. </context> | us-gaap:CommercialPaper |
Includes $ 900 million aggregate bank commitment related to Exelon Corporate. Exelon Corporate had $ 3 million outstanding letters of credit as of December 31, 2023. Exelon Corporate had $ 370 million in available capacity to support additional commercial paper as of December 31, 2023. | text | 900 | monetaryItemType | text: <entity> 900 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 900 million aggregate bank commitment related to Exelon Corporate. Exelon Corporate had $ 3 million outstanding letters of credit as of December 31, 2023. Exelon Corporate had $ 370 million in available capacity to support additional commercial paper as of December 31, 2023. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
Includes $ 900 million aggregate bank commitment related to Exelon Corporate. Exelon Corporate had $ 3 million outstanding letters of credit as of December 31, 2023. Exelon Corporate had $ 370 million in available capacity to support additional commercial paper as of December 31, 2023. | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 900 million aggregate bank commitment related to Exelon Corporate. Exelon Corporate had $ 3 million outstanding letters of credit as of December 31, 2023. Exelon Corporate had $ 370 million in available capacity to support additional commercial paper as of December 31, 2023. </context> | us-gaap:LettersOfCreditOutstandingAmount |
Includes $ 900 million aggregate bank commitment related to Exelon Corporate. Exelon Corporate had $ 3 million outstanding letters of credit as of December 31, 2023. Exelon Corporate had $ 370 million in available capacity to support additional commercial paper as of December 31, 2023. | text | 370 | monetaryItemType | text: <entity> 370 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 900 million aggregate bank commitment related to Exelon Corporate. Exelon Corporate had $ 3 million outstanding letters of credit as of December 31, 2023. Exelon Corporate had $ 370 million in available capacity to support additional commercial paper as of December 31, 2023. </context> | us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity |
Includes interest rate adders at Exelon Corporate of 27.5 basis points and 127.5 basis points for prime and SOFR-based borrowings, respectively. | text | 27.5 | percentItemType | text: <entity> 27.5 </entity> <entity type> percentItemType </entity type> <context> Includes interest rate adders at Exelon Corporate of 27.5 basis points and 127.5 basis points for prime and SOFR-based borrowings, respectively. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
Includes interest rate adders at Exelon Corporate of 27.5 basis points and 127.5 basis points for prime and SOFR-based borrowings, respectively. | text | 127.5 | percentItemType | text: <entity> 127.5 </entity> <entity type> percentItemType </entity type> <context> Includes interest rate adders at Exelon Corporate of 27.5 basis points and 127.5 basis points for prime and SOFR-based borrowings, respectively. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
On March 23, 2017, Exelon Corporate entered into a term loan agreement for $ 500 million. The loan agreement was renewed in the first quarter of 2023 and was bifurcated into two tranches of $ 300 million on March 14, 2023 and $ 200 million on March 24, 2023. The agreements will expire on March 14, 2024 and March 22, 2024, respectively. Pursuant to the loan agreements, loans made thereunder bear interest at a variable rate equal to SOFR plus 0.90 % and all indebtedness thereunder is unsecured. The loan agreement is reflected in Exelon's Consolidated Balance Sheets within Short-term borrowings. | text | 500 | monetaryItemType | text: <entity> 500 </entity> <entity type> monetaryItemType </entity type> <context> On March 23, 2017, Exelon Corporate entered into a term loan agreement for $ 500 million. The loan agreement was renewed in the first quarter of 2023 and was bifurcated into two tranches of $ 300 million on March 14, 2023 and $ 200 million on March 24, 2023. The agreements will expire on March 14, 2024 and March 22, 2024, respectively. Pursuant to the loan agreements, loans made thereunder bear interest at a variable rate equal to SOFR plus 0.90 % and all indebtedness thereunder is unsecured. The loan agreement is reflected in Exelon's Consolidated Balance Sheets within Short-term borrowings. </context> | us-gaap:ShortTermBankLoansAndNotesPayable |
On March 23, 2017, Exelon Corporate entered into a term loan agreement for $ 500 million. The loan agreement was renewed in the first quarter of 2023 and was bifurcated into two tranches of $ 300 million on March 14, 2023 and $ 200 million on March 24, 2023. The agreements will expire on March 14, 2024 and March 22, 2024, respectively. Pursuant to the loan agreements, loans made thereunder bear interest at a variable rate equal to SOFR plus 0.90 % and all indebtedness thereunder is unsecured. The loan agreement is reflected in Exelon's Consolidated Balance Sheets within Short-term borrowings. | text | 300 | monetaryItemType | text: <entity> 300 </entity> <entity type> monetaryItemType </entity type> <context> On March 23, 2017, Exelon Corporate entered into a term loan agreement for $ 500 million. The loan agreement was renewed in the first quarter of 2023 and was bifurcated into two tranches of $ 300 million on March 14, 2023 and $ 200 million on March 24, 2023. The agreements will expire on March 14, 2024 and March 22, 2024, respectively. Pursuant to the loan agreements, loans made thereunder bear interest at a variable rate equal to SOFR plus 0.90 % and all indebtedness thereunder is unsecured. The loan agreement is reflected in Exelon's Consolidated Balance Sheets within Short-term borrowings. </context> | us-gaap:ShortTermBankLoansAndNotesPayable |
On March 23, 2017, Exelon Corporate entered into a term loan agreement for $ 500 million. The loan agreement was renewed in the first quarter of 2023 and was bifurcated into two tranches of $ 300 million on March 14, 2023 and $ 200 million on March 24, 2023. The agreements will expire on March 14, 2024 and March 22, 2024, respectively. Pursuant to the loan agreements, loans made thereunder bear interest at a variable rate equal to SOFR plus 0.90 % and all indebtedness thereunder is unsecured. The loan agreement is reflected in Exelon's Consolidated Balance Sheets within Short-term borrowings. | text | 200 | monetaryItemType | text: <entity> 200 </entity> <entity type> monetaryItemType </entity type> <context> On March 23, 2017, Exelon Corporate entered into a term loan agreement for $ 500 million. The loan agreement was renewed in the first quarter of 2023 and was bifurcated into two tranches of $ 300 million on March 14, 2023 and $ 200 million on March 24, 2023. The agreements will expire on March 14, 2024 and March 22, 2024, respectively. Pursuant to the loan agreements, loans made thereunder bear interest at a variable rate equal to SOFR plus 0.90 % and all indebtedness thereunder is unsecured. The loan agreement is reflected in Exelon's Consolidated Balance Sheets within Short-term borrowings. </context> | us-gaap:ShortTermBankLoansAndNotesPayable |
On March 23, 2017, Exelon Corporate entered into a term loan agreement for $ 500 million. The loan agreement was renewed in the first quarter of 2023 and was bifurcated into two tranches of $ 300 million on March 14, 2023 and $ 200 million on March 24, 2023. The agreements will expire on March 14, 2024 and March 22, 2024, respectively. Pursuant to the loan agreements, loans made thereunder bear interest at a variable rate equal to SOFR plus 0.90 % and all indebtedness thereunder is unsecured. The loan agreement is reflected in Exelon's Consolidated Balance Sheets within Short-term borrowings. | text | 0.90 | percentItemType | text: <entity> 0.90 </entity> <entity type> percentItemType </entity type> <context> On March 23, 2017, Exelon Corporate entered into a term loan agreement for $ 500 million. The loan agreement was renewed in the first quarter of 2023 and was bifurcated into two tranches of $ 300 million on March 14, 2023 and $ 200 million on March 24, 2023. The agreements will expire on March 14, 2024 and March 22, 2024, respectively. Pursuant to the loan agreements, loans made thereunder bear interest at a variable rate equal to SOFR plus 0.90 % and all indebtedness thereunder is unsecured. The loan agreement is reflected in Exelon's Consolidated Balance Sheets within Short-term borrowings. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
On October 4, 2022, ComEd entered into a 364-day term loan agreement for $ 150 million with a variable rate equal to SOFR plus 0.75 % and an expiration date of October 3, 2023. The proceeds from this loan were used to repay outstanding commercial paper obligations. The loan agreement is reflected in Exelon's and ComEd's Consolidated Balance Sheets within Short-term borrowings. The balance of the loan was repaid on January 13, 2023 in conjunction with the $ 400 million and $ 575 million First Mortgage Bond agreements that were entered into on January 3, 2023. | text | 0.75 | percentItemType | text: <entity> 0.75 </entity> <entity type> percentItemType </entity type> <context> On October 4, 2022, ComEd entered into a 364-day term loan agreement for $ 150 million with a variable rate equal to SOFR plus 0.75 % and an expiration date of October 3, 2023. The proceeds from this loan were used to repay outstanding commercial paper obligations. The loan agreement is reflected in Exelon's and ComEd's Consolidated Balance Sheets within Short-term borrowings. The balance of the loan was repaid on January 13, 2023 in conjunction with the $ 400 million and $ 575 million First Mortgage Bond agreements that were entered into on January 3, 2023. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
On October 4, 2022, ComEd entered into a 364-day term loan agreement for $ 150 million with a variable rate equal to SOFR plus 0.75 % and an expiration date of October 3, 2023. The proceeds from this loan were used to repay outstanding commercial paper obligations. The loan agreement is reflected in Exelon's and ComEd's Consolidated Balance Sheets within Short-term borrowings. The balance of the loan was repaid on January 13, 2023 in conjunction with the $ 400 million and $ 575 million First Mortgage Bond agreements that were entered into on January 3, 2023. | text | 400 | monetaryItemType | text: <entity> 400 </entity> <entity type> monetaryItemType </entity type> <context> On October 4, 2022, ComEd entered into a 364-day term loan agreement for $ 150 million with a variable rate equal to SOFR plus 0.75 % and an expiration date of October 3, 2023. The proceeds from this loan were used to repay outstanding commercial paper obligations. The loan agreement is reflected in Exelon's and ComEd's Consolidated Balance Sheets within Short-term borrowings. The balance of the loan was repaid on January 13, 2023 in conjunction with the $ 400 million and $ 575 million First Mortgage Bond agreements that were entered into on January 3, 2023. </context> | us-gaap:DebtInstrumentFaceAmount |
On October 4, 2022, ComEd entered into a 364-day term loan agreement for $ 150 million with a variable rate equal to SOFR plus 0.75 % and an expiration date of October 3, 2023. The proceeds from this loan were used to repay outstanding commercial paper obligations. The loan agreement is reflected in Exelon's and ComEd's Consolidated Balance Sheets within Short-term borrowings. The balance of the loan was repaid on January 13, 2023 in conjunction with the $ 400 million and $ 575 million First Mortgage Bond agreements that were entered into on January 3, 2023. | text | 575 | monetaryItemType | text: <entity> 575 </entity> <entity type> monetaryItemType </entity type> <context> On October 4, 2022, ComEd entered into a 364-day term loan agreement for $ 150 million with a variable rate equal to SOFR plus 0.75 % and an expiration date of October 3, 2023. The proceeds from this loan were used to repay outstanding commercial paper obligations. The loan agreement is reflected in Exelon's and ComEd's Consolidated Balance Sheets within Short-term borrowings. The balance of the loan was repaid on January 13, 2023 in conjunction with the $ 400 million and $ 575 million First Mortgage Bond agreements that were entered into on January 3, 2023. </context> | us-gaap:DebtInstrumentFaceAmount |
On May 9, 2023, ComEd entered into a 364-day term loan agreement for $ 400 million with a variable rate equal to SOFR plus 1.00 % and an expiration date of May 7, 2024. The proceeds from this loan were used to repay outstanding commercial paper obligations and for general corporate purposes. The loan agreement is reflected in Exelon's and ComEd's Consolidated Balance Sheets within Short-term borrowings. | text | 400 | monetaryItemType | text: <entity> 400 </entity> <entity type> monetaryItemType </entity type> <context> On May 9, 2023, ComEd entered into a 364-day term loan agreement for $ 400 million with a variable rate equal to SOFR plus 1.00 % and an expiration date of May 7, 2024. The proceeds from this loan were used to repay outstanding commercial paper obligations and for general corporate purposes. The loan agreement is reflected in Exelon's and ComEd's Consolidated Balance Sheets within Short-term borrowings. </context> | us-gaap:ShortTermBankLoansAndNotesPayable |
On May 9, 2023, ComEd entered into a 364-day term loan agreement for $ 400 million with a variable rate equal to SOFR plus 1.00 % and an expiration date of May 7, 2024. The proceeds from this loan were used to repay outstanding commercial paper obligations and for general corporate purposes. The loan agreement is reflected in Exelon's and ComEd's Consolidated Balance Sheets within Short-term borrowings. | text | 1.00 | percentItemType | text: <entity> 1.00 </entity> <entity type> percentItemType </entity type> <context> On May 9, 2023, ComEd entered into a 364-day term loan agreement for $ 400 million with a variable rate equal to SOFR plus 1.00 % and an expiration date of May 7, 2024. The proceeds from this loan were used to repay outstanding commercial paper obligations and for general corporate purposes. The loan agreement is reflected in Exelon's and ComEd's Consolidated Balance Sheets within Short-term borrowings. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
Pursuant to the loan agreement, loans made thereunder bear interest at a variable rate equal to SOFR plus 0.85 %. | text | 0.85 | percentItemType | text: <entity> 0.85 </entity> <entity type> percentItemType </entity type> <context> Pursuant to the loan agreement, loans made thereunder bear interest at a variable rate equal to SOFR plus 0.85 %. </context> | us-gaap:SubordinatedBorrowingInterestRate |
Includes $ 390 million due to ComEd and PECO financing trusts. | text | 390 | monetaryItemType | text: <entity> 390 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 390 million due to ComEd and PECO financing trusts. </context> | us-gaap:LongTermDebt |
Includes $ 206 million due to ComEd financing trust. | text | 206 | monetaryItemType | text: <entity> 206 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 206 million due to ComEd financing trust. </context> | us-gaap:LongTermDebt |
Includes $ 184 million due to PECO financing trusts. | text | 184 | monetaryItemType | text: <entity> 184 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 184 million due to PECO financing trusts. </context> | us-gaap:LongTermDebt |
In connection with the debt obligations assumed by Exelon as part of the Constellation merger, Exelon and subsidiaries of Generation (former Constellation subsidiaries) entered into intercompany loan agreements that mirror the terms and amounts of the third-party debt obligations of Exelon, resulting in intercompany notes receivable at Exelon Corporate from Generation. In connection with the separation, on January 31, 2022, Exelon Corporate received cash from Generation of $ 258 million to settle the intercompany loan. | text | 258 | monetaryItemType | text: <entity> 258 </entity> <entity type> monetaryItemType </entity type> <context> In connection with the debt obligations assumed by Exelon as part of the Constellation merger, Exelon and subsidiaries of Generation (former Constellation subsidiaries) entered into intercompany loan agreements that mirror the terms and amounts of the third-party debt obligations of Exelon, resulting in intercompany notes receivable at Exelon Corporate from Generation. In connection with the separation, on January 31, 2022, Exelon Corporate received cash from Generation of $ 258 million to settle the intercompany loan. </context> | us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable |
Excludes cash of $ 334 million and $ 345 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 149 million and $ 81 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. | text | 334 | monetaryItemType | text: <entity> 334 </entity> <entity type> monetaryItemType </entity type> <context> Excludes cash of $ 334 million and $ 345 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 149 million and $ 81 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
Excludes cash of $ 334 million and $ 345 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 149 million and $ 81 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. | text | 345 | monetaryItemType | text: <entity> 345 </entity> <entity type> monetaryItemType </entity type> <context> Excludes cash of $ 334 million and $ 345 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 149 million and $ 81 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
Excludes cash of $ 334 million and $ 345 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 149 million and $ 81 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. | text | 149 | monetaryItemType | text: <entity> 149 </entity> <entity type> monetaryItemType </entity type> <context> Excludes cash of $ 334 million and $ 345 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 149 million and $ 81 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
Excludes cash of $ 334 million and $ 345 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 149 million and $ 81 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. | text | 81 | monetaryItemType | text: <entity> 81 </entity> <entity type> monetaryItemType </entity type> <context> Excludes cash of $ 334 million and $ 345 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 149 million and $ 81 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
Excludes cash of $ 334 million and $ 345 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 149 million and $ 81 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. | text | 174 | monetaryItemType | text: <entity> 174 </entity> <entity type> monetaryItemType </entity type> <context> Excludes cash of $ 334 million and $ 345 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 149 million and $ 81 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
Excludes cash of $ 334 million and $ 345 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 149 million and $ 81 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. | text | 117 | monetaryItemType | text: <entity> 117 </entity> <entity type> monetaryItemType </entity type> <context> Excludes cash of $ 334 million and $ 345 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 149 million and $ 81 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. | text | 86 | monetaryItemType | text: <entity> 86 </entity> <entity type> monetaryItemType </entity type> <context> ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. | text | 42 | monetaryItemType | text: <entity> 42 </entity> <entity type> monetaryItemType </entity type> <context> ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. | text | 147 | monetaryItemType | text: <entity> 147 </entity> <entity type> monetaryItemType </entity type> <context> ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. | text | 77 | monetaryItemType | text: <entity> 77 </entity> <entity type> monetaryItemType </entity type> <context> ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. | text | 174 | monetaryItemType | text: <entity> 174 </entity> <entity type> monetaryItemType </entity type> <context> ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. | text | 117 | monetaryItemType | text: <entity> 117 </entity> <entity type> monetaryItemType </entity type> <context> ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. | text | 58 | monetaryItemType | text: <entity> 58 </entity> <entity type> monetaryItemType </entity type> <context> ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. | text | 47 | monetaryItemType | text: <entity> 47 </entity> <entity type> monetaryItemType </entity type> <context> ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. | text | 43 | monetaryItemType | text: <entity> 43 </entity> <entity type> monetaryItemType </entity type> <context> ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> ComEd excludes cash of $ 86 million and $ 42 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 147 million and $ 77 million at December 31, 2023 and 2022, respectively, and includes long-term restricted cash of $ 174 million and $ 117 million at December 31, 2023 and 2022, respectively, which is reported in Other deferred debits in the Consolidated Balance Sheets. PECO excludes cash of $ 42 million and $ 58 million at December 31, 2023 and 2022, respectively. BGE excludes cash of $ 47 million and $ 43 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 1 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
The Level 3 balance consists of the current and noncurrent liability of $ 27 million and $ 106 million, respectively, at December 31, 2023, and $ 5 million and $ 79 million, respectively, at December 31, 2022 related to floating-to-fixed energy swap contracts with unaffiliated suppliers. | text | 27 | monetaryItemType | text: <entity> 27 </entity> <entity type> monetaryItemType </entity type> <context> The Level 3 balance consists of the current and noncurrent liability of $ 27 million and $ 106 million, respectively, at December 31, 2023, and $ 5 million and $ 79 million, respectively, at December 31, 2022 related to floating-to-fixed energy swap contracts with unaffiliated suppliers. </context> | us-gaap:DerivativeLiabilitiesCurrent |
The Level 3 balance consists of the current and noncurrent liability of $ 27 million and $ 106 million, respectively, at December 31, 2023, and $ 5 million and $ 79 million, respectively, at December 31, 2022 related to floating-to-fixed energy swap contracts with unaffiliated suppliers. | text | 106 | monetaryItemType | text: <entity> 106 </entity> <entity type> monetaryItemType </entity type> <context> The Level 3 balance consists of the current and noncurrent liability of $ 27 million and $ 106 million, respectively, at December 31, 2023, and $ 5 million and $ 79 million, respectively, at December 31, 2022 related to floating-to-fixed energy swap contracts with unaffiliated suppliers. </context> | us-gaap:DerivativeLiabilitiesNoncurrent |
The Level 3 balance consists of the current and noncurrent liability of $ 27 million and $ 106 million, respectively, at December 31, 2023, and $ 5 million and $ 79 million, respectively, at December 31, 2022 related to floating-to-fixed energy swap contracts with unaffiliated suppliers. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> The Level 3 balance consists of the current and noncurrent liability of $ 27 million and $ 106 million, respectively, at December 31, 2023, and $ 5 million and $ 79 million, respectively, at December 31, 2022 related to floating-to-fixed energy swap contracts with unaffiliated suppliers. </context> | us-gaap:DerivativeLiabilitiesCurrent |
The Level 3 balance consists of the current and noncurrent liability of $ 27 million and $ 106 million, respectively, at December 31, 2023, and $ 5 million and $ 79 million, respectively, at December 31, 2022 related to floating-to-fixed energy swap contracts with unaffiliated suppliers. | text | 79 | monetaryItemType | text: <entity> 79 </entity> <entity type> monetaryItemType </entity type> <context> The Level 3 balance consists of the current and noncurrent liability of $ 27 million and $ 106 million, respectively, at December 31, 2023, and $ 5 million and $ 79 million, respectively, at December 31, 2022 related to floating-to-fixed energy swap contracts with unaffiliated suppliers. </context> | us-gaap:DerivativeLiabilitiesNoncurrent |
PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. | text | 96 | monetaryItemType | text: <entity> 96 </entity> <entity type> monetaryItemType </entity type> <context> PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. | text | 165 | monetaryItemType | text: <entity> 165 </entity> <entity type> monetaryItemType </entity type> <context> PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. | text | 48 | monetaryItemType | text: <entity> 48 </entity> <entity type> monetaryItemType </entity type> <context> PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. | text | 45 | monetaryItemType | text: <entity> 45 </entity> <entity type> monetaryItemType </entity type> <context> PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. | text | 15 | monetaryItemType | text: <entity> 15 </entity> <entity type> monetaryItemType </entity type> <context> PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. | text | 31 | monetaryItemType | text: <entity> 31 </entity> <entity type> monetaryItemType </entity type> <context> PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.